10x Genomics, Inc.
MX ˙ BMV ˙ US88025U1097
SecurityMX:TXG / 10x Genomics, Inc.
InstitutionAlliancebernstein L.p.
Latest Disclosed Ownership125,131 shares
Latest Disclosed Value $ 2,040,887
Alliancebernstein L.p. reports 0.85% decrease in ownership of TXG / 10x Genomics, Inc.

On May 15, 2026 - Alliancebernstein L.p. filed a 13F-HR form disclosing ownership of 125,131 shares of 10x Genomics, Inc. (MX:TXG) valued at $2,040,887 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 126,200 shares of 10x Genomics, Inc.. This represents a change in shares of -0.85% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F 10X GENOMICS CL A COM 88025U109 125,131 -1,069 -0.85 2,041 -0.87 0.0007
2026-02-17 2025-12-31 13F 10X GENOMICS CL A COM 88025U109 126,200 0 0.00 2,058 39.53 0.0006
2025-11-14 2025-09-30 13F 10X GENOMICS CL A COM 88025U109 126,200 -307 -0.24 1,475 0.75 0.0005
2025-08-14 2025-06-30 13F 10X GENOMICS CL A COM 88025U109 126,507 90,988 256.17 1,465 372.26 0.0005
2025-05-15 2025-03-31 13F 10X GENOMICS CL A COM 88025U109 35,519 24 0.07 310 -39.10 0.0001
2025-02-12 2024-12-31 13F 10X GENOMICS CL A COM 88025U109 35,495 -353 -0.98 510 -37.08 0.0002
2024-11-14 2024-09-30 13F 10X GENOMICS CL A COM 88025U109 35,848 -6,670 -15.69 809 -2.06 0.0003
2024-08-14 2024-06-30 13F 10X GENOMICS CL A COM 88025U109 42,518 11,224 35.87 827 -29.64 0.0003
2024-05-14 2024-03-31 13F 10X GENOMICS CL A COM 88025U109 31,294 660 2.15 1,174 -31.51 0.0004
2024-02-14 2023-12-31 13F 10X GENOMICS CL A COM 88025U109 30,634 1,248 4.25 1,714 41.42 0.0007
2023-11-14 2023-09-30 13F 10X GENOMICS CL A COM 88025U109 29,386 -888 -2.93 1,212 -28.28 0.0005
2023-08-15 2023-06-30 13F 10X GENOMICS CL A COM 88025U109 30,274 -320 -1.05 1,690 -0.94 0.0007
2023-05-15 2023-03-31 13F 10X GENOMICS CL A COM 88025U109 30,594 -6,325 -17.13 1,707 26.84 0.0007
2023-02-15 2022-12-31 13F 10X GENOMICS CL A COM 88025U109 36,919 130 0.35 1,345 28.34 0.0006
2022-11-15 2022-09-30 13F 10X GENOMICS CL A COM 88025U109 36,789 69 0.19 1,048 -36.94 0.0005
2022-08-15 2022-06-30 13F 10X GENOMICS CL A COM 88025U109 36,720 664 1.84 1,662 -39.41 0.0008
2022-05-13 2022-03-31 13F 10X GENOMICS CL A COM 88025U109 36,056 -780,682 -95.59 2,743 -97.75 0.0011
2022-02-14 2021-12-31 13F 10X GENOMICS CL A COM 88025U109 816,738 73,255 9.85 121,661 12.40 0.0430
2021-11-10 2021-09-30 13F 10X GENOMICS CL A COM 88025U109 743,483 89,390 13.67 108,236 -15.50 0.0427
2021-07-30 2021-06-30 13F 10X GENOMICS CL A COM 88025U109 654,093 22,112 3.50 128,084 11.97 0.0514
2021-05-06 2021-03-31 13F 10X GENOMICS CL A COM 88025U109 631,981 -150,344 -19.22 114,389 3.26 0.0502
2021-02-08 2020-12-31 13F 10X GENOMICS CL A COM 88025U109 782,325 -448,131 -36.42 110,777 -27.79 0.0523
2020-11-12 2020-09-30 13F 10X GENOMICS CL A COM 88025U109 1,230,456 -301,794 -19.70 153,413 12.11 0.0826
2020-08-13 2020-06-30 13F 10X GENOMICS CL A COM 88025U109 1,532,250 -40,760 -2.59 136,845 39.60 0.0804
2020-05-14 2020-03-31 13F 10X GENOMICS CL A COM 88025U109 1,573,010 594,693 60.79 98,030 31.41 0.0703
2020-02-18 2019-12-31 13F 10X GENOMICS CL A COM 88025U109 978,317 679,482 227.38 74,597 395.30 0.0424
2019-11-14 2019-09-30 13F 10X GENOMICS CL A COM 88025U109 298,835 298,835 15,061 0.0094
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.